Antiretroviral drug activity and potential for pre-exposure prophylaxis against COVID-19 and HIV infectionArticle Published on 2022-10-012023-07-06 Journal: Journal of biomolecular structure & dynamics [Category] COVID19(2023년), [키워드] Antiretrovirals COVID-19 docking HIV PrEP SARS-CoV-2 [DOI] 10.1080/07391102.2021.1901144
The Elegance of the Acyclic Nucleoside Phosphonates (ANPs), Honorary Tribute to Antonín Holý, Who Passed Away on 16 July 2012, at the 10th Anniversary of His DeathEditorial Published on 2022-09-072023-06-12 Journal: Viruses [Category] B형 간염, [키워드] Adefovir ANPs Cidofovir HBV HIV PrEP TAF TDF tenofovir [DOI] 10.3390/v14091978 PMC 바로가기 [Article Type] Editorial
Impact of Coronavirus Disease 2019 (COVID-19) on Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis Prescriptions in the United States-A Time-Series Analysis코로나바이러스 질병 2019(COVID-19)가 인간 면역결핍 바이러스(HIV)에 미치는 영향 미국의 사전 노출 예방 처방-시계열 분석Article Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] 치료제, [키워드] 95% CI absence affected Algorithm analyzed COVID-19 COVID-19 pandemic database decrease FDA approval greater highlighting HIV Human Impact Intervention maintain National Observed occurred outcome pandemic pre-exposure prophylaxis predicted PrEP prescription Prophylaxis quantified rate ratio reduction the United State The United States United States uptake [DOI] 10.1093/cid/ciac038 PMC 바로가기 [Article Type] Article
SARS-CoV-2 pre-exposure prophylaxis: A potential COVID-19 preventive strategy for high-risk populations, including healthcare workers, immunodeficient individuals, and poor vaccine respondersSARS-CoV-2 노출 전 예방: 의료 종사자, 면역 결핍 개인, 백신 반응 불량자를 포함한 고위험 인구를 위한 잠재적인 COVID-19 예방 전략Review Published on 2022-08-082022-09-11 Journal: Frontiers in Public Health [Category] SARS, 변종, 치료제, [키워드] addition administration anti-SARS-CoV-2 Antibody titer Antiviral antiviral drugs benefit building complementary contributing to COVID-19 COVID-19 patient COVID-19 vaccine COVID-19 vaccines creating drug drug combination drugs effective framework Health care health care systems healthcare Healthcare workers high-risk population HIV HIV disease individuals Infection knowledge limit molnupiravir new virus Nirmatrelvir outcomes pandemic Paxlovid populations pre-exposure prophylaxis (PrEP) PrEP Prevent progression Prophylaxis Protective Protective antibody Remdesivir Responder responders restrict risk factor Risk factors Ritonavir SARS-CoV-2 SARS-COV-2 infection secondary to severe COVID-19 severity shown Spread suppressed Transmission uninfected Vaccine variants widespread [DOI] 10.3389/fpubh.2022.945448 PMC 바로가기 [Article Type] Review
Acceptability and feasibility of leveraging community-based HIV counselling and testing platforms for same-day oral PrEP initiation among adolescent girls and young women in Eastern Cape, South Africa남아프리카 공화국 이스턴 케이프의 청소년 소녀와 젊은 여성을 대상으로 당일 구두 PrEP 시작을 위한 커뮤니티 기반 HIV 상담 및 테스트 플랫폼 활용의 수용 가능성 및 타당성Article Published on 2022-07-012022-09-11 Journal: Journal of the International AIDS Society [Category] 치료제, [키워드] acceptability acquisition adolescent girls and young women African available data baseline Cape Care cohort characteristics community-based HIV testing Complete COVID-19 pandemic Descriptive statistics detectable differentiated care. eligibility facilitate feasibility Health high risk HIV HIV prevention HIV testing HIV-negative Infection initiated integration measure medication platform post-hoc PrEP Prevalence Prophylaxis proportion questionnaire reported required risk Risk assessment sexually transmitted infection South South Africa study participant tent tested transmitted were measured women [DOI] 10.1002/jia2.25968 PMC 바로가기 [Article Type] Article
Proline-specific peptidase activities (DPP4, PRCP, FAP and PREP) in plasma of hospitalized COVID-19 patients입원한 COVID-19 환자의 혈장에서 프롤린 특이적 펩티다제 활성(DPP4, PRCP, FAP 및 PREP)Article Published on 2022-06-012022-09-11 Journal: Clinica chimica acta; international journal of cli [Category] MERS, 바이오마커, 진단, [키워드] Activation activities activity Alpha Biomarker changes in collected coronavirus COVID-19 COVID-19 patient COVID-19 patients decrease dipeptidyl peptidase Dipeptidyl peptidase 4 discharge DPP4 dysregulated dysregulation elevated FAP feature fibroblast Fibroblast activation protein alpha Follow-up healthy control healthy controls Hospital admission Hospital stay Hospitalization hospitalized COVID-19 patient hospitalized COVID-19 patients immune system investigated pathophysiological patients peptidase plasma PRCP PrEP proline Prolyl oligopeptidase Prolylcarboxypeptidase. Protein remained Sepsis Septic shock significantly significantly increased significantly lower utility were measured while [DOI] 10.1016/j.cca.2022.03.005 PMC 바로가기 [Article Type] Article
Maintaining access to HIV pre-exposure prophylaxis in a pandemic: A service evaluation of telephone-based pre-exposure prophylaxis provision대유행에서 HIV 노출 전 예방에 대한 접근 유지: 전화 기반 노출 전 예방 제공 서비스 평가Article Published on 2022-06-012022-09-11 Journal: International Journal of STD & AIDS [Category] 치료제, [키워드] Administered Care change clinics convenience COVID-19 COVID-19 pandemic delivery Descriptive statistics expressed feasible framework hcp healthcare Healthcare professional HIV HIV pre-exposure prophylaxis increase in maintaining management Patient Patient experience pre-exposure prophylaxis preference PrEP Prophylaxis qualitative data remote Remote access to care required resources response service System Teamwork Tele-medicine the patient turn while [DOI] 10.1177/09564624211068766 PMC 바로가기 [Article Type] Article
IgG seroprevalence of COVID-19 among people living with HIV or at high risk of HIV in south-west Germany: A seroprevalence study독일 남서부의 HIV 감염자 또는 HIV 고위험군에서 COVID-19의 IgG 혈청 유병률: 혈청 유병률 연구Article Published on 2022-05-012022-09-11 Journal: HIV medicine [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] antibody Antibody Response best carried Cohort comparable conducted COVID-19 COVID-19 diagnosis COVID-19-related symptom COVID-19-related symptoms cross-sectional cross-sectional study detect diagnosed diagnosis of COVID-19 female FIVE Germany help high risk HIV hospital Hospitalized IgG Immunoglobulin Immunoglobulin G Inclusion Infection knowledge limitation male median age pandemic Patient patients PCR-positive patient PLWH PLWH cohort positive predict PrEP Prophylaxis questionnaire Questionnaires receiving reported Risk factors SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 positive patients Serological testing Seroprevalence shown tested the patient was performed with HIV [DOI] 10.1111/hiv.13207 PMC 바로가기 [Article Type] Article
HIV Prevention in a Time of COVID-19: A Report from the HIVR4P // Virtual Conference 2021Article Published on 2022-05-012023-06-17 Journal: AIDS research and human retroviruses [Category] MERS, [키워드] Antiretrovirals broadly neutralizing antibodies (bNAbs) clinical trials HIV HIVR4P Microbicides PrEP prevention South Africa TaSP Vaccine [DOI] 10.1089/aid.2021.0138 PMC 바로가기
Pre-exposure prophylaxis (PrEP) uptake and service delivery adaptations during the first wave of the COVID-19 pandemic in 21 PEPFAR-funded countriesPEPFAR 자금 지원을 받는 21개 국가에서 COVID-19 전염병의 첫 번째 물결 동안 사전 노출 예방(PrEP) 섭취 및 서비스 제공 적응Article Published on 2022-04-052022-09-11 Journal: PLoS ONE [Category] 치료제, [키워드] adaptation AIDS analyzed calculated changes in country Coverage COVID COVID-19 COVID-19 pandemic defined Emergency examined First wave FIVE health system health systems initiated maintain measure methodology Mitigation MMD monitoring number of persons plan Population PrEP President Prophylaxis relief Reporting routine monitoring significant increases in supported women [DOI] 10.1371/journal.pone.0266280 PMC 바로가기 [Article Type] Article